Schroder Investment Management Group
CSTL icon

Schroder Investment Management Group’s Castle Biosciences CSTL Stock Holding History

Schroder Investment Management Group’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.04M Sell
298,941
-193,220
-39% -$6.33M 0.01% 730
2025
Q4 		$19.3M Sell
492,161
-2,789
-0.6% -$89.9K 0.01% 516
2025
Q3 		$11.1M Sell
494,950
-153,622
-24% -$3.12M 0.01% 646
2025
Q2 		$13.2M Buy
648,572
+51,483
+9% +$953K 0.01% 584
2025
Q1 		$11.9M Buy
+597,089
New +$14.8M 0.01% 607

Other funds holding CSTL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Schroder Investment Management Group's CSTL Position: Q1 2026 in Review

Schroder Investment Management Group reduced its Castle Biosciences (CSTL) stake by 39% in Q1 2026, selling an estimated $6.33M and leaving 298,941 shares worth $7.04M. The position accounts for 0.01% of the portfolio, ranked #730.

Schroder Investment Management Group first reported a position in CSTL in Q1 2025 and has held it in 5 quarters since. The position peaked at $19.3M in Q4 2025. 186 funds tracked by Wall St. Rank hold CSTL as of Q1 2026.

  • Schroder Investment Management Group held 298,941 shares of Castle Biosciences worth $7.04M as of Q1 2026.
  • Schroder Investment Management Group sold 193,220 Castle Biosciences shares in Q1 2026, an estimated $6.33M.
  • Castle Biosciences made up 0.01% of Schroder Investment Management Group's portfolio in Q1 2026, its #730 holding.
  • Schroder Investment Management Group first reported a position in Castle Biosciences in Q1 2025 and has held it in 5 quarters since.
  • Schroder Investment Management Group's Castle Biosciences position peaked at $19.3M in Q4 2025.
  • 186 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2026.

Based on Schroder Investment Management Group's 13F filing for Q1 2026, filed 14 May 2026.